Results 101 to 110 of about 3,549 (185)

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients

Biologics: Targets & Therapy, 2016
Roberto Guariglia,1 Maria Carmen Martorelli,1 Rosa Lerose,2 Donatella Telesca,2 Maria Rita Milella,2 Pellegrino Musto3 1Unit of Hematology and Stem Cell Transplantation, 2Pharmacy Service, 3Scientific Direction, IRCCS, Referral Cancer Center of ...
Guariglia R, Martorelli MC, Lerose R, Telesca D, Milella MR, Musto P   +5 more
doaj  

Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. [PDF]

In Vivo
Sato R, Yoshimi Y, Nishio T, Matsunaga YU, Matsumoto R.   +4 more
europepmc   +1 more source

Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer

, 2015
Purpose: The aim of this study was to compare the effectiveness of prophylactic single fixed dose of pegfilgrastim and daily administration of filgrastim on febrile neutropenia (FN), severe neutropenia, treatment delay, and dose reduction in patients ...
Skarlos, Dimosthenis V, Skarlos, D.V., Fountzilas, G., Pectasides, Dimitrios, Gogas, H., Kourlaba, Georgia, Pentheroudakis, G., Pectasides, D., Fountzilas, George, Gogas, Helen, Kourlaba, G., Maniadakis, N., Maniadakis, Nikos, Koutras, Angelos, Dimopoulos, M.A., Pentheroudakis, George, Dimopoulos, Meletios A, Koutras, A.   +17 more
core  

Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany. [PDF]

Support Care Cancer
Steinmetz T, Jungberg P, Guth D, Knoblich J, Fietz T, Göhler T, Reiser M, Totzke U, Bernhardt K.   +8 more
europepmc   +1 more source

Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: Can we decide?

, 2012
Granulocyte-colony-stimulating factors are helpful for the support of patients receiving autologous hematopoietic stem cell transplantation, resulting in faster neutrophil recovery and lower incidence of febrile neutropenia (FN).
Kourbeti, I.S., Ziakas, P.D.
core  

The safety and effectiveness of pegfilgrastim to reduce cancer chemotherapy-induced febrile neutropenia in real-world practice in Japan: a post-marketing surveillance study. [PDF]

Support Care Cancer
Shibata N, Kuwazawa H, Yasukawa T, Iwabuchi M, Saji S.   +4 more
europepmc   +1 more source

Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer. [PDF]

JNCI Cancer Spectr
Ali A, Barlow WE, Moore HCF, Hobday TJ, Isaacs C, Salim M, Albain KS, Chew HK, Burton GV, Srkalovic G, McGregor BA, Flaherty LE, Lew DL, Gralow JR, Hortobagyi GN, Sharma P, Pusztai L, Budd GT.   +17 more
europepmc   +1 more source

ST-Segment Elevation Myocardial Infarction After Pegfilgrastim: Case Report and Review of Mechanistic Considerations. [PDF]

JACC Case Rep
Goetze C, Dreger H, Chiu CY.
europepmc   +1 more source

Pegfilgrastim (Neulasta)-induced acute aortitis: a case report. [PDF]

Eur Heart J Case Rep
Marlecha P, Kapadia S, Rosenzveig A, Wolff R, Nanjundappa A.   +4 more
europepmc   +1 more source

Prophylactic Pegfilgrastim Versus On-Demand Filgrastim During Docetaxel and Cyclophosphamide Chemotherapy in Early-Stage Breast Cancer: A Retrospective Analysis. [PDF]

Cureus
Banno H, Fujii K, Ohashi W, Ozaki K, Saitou M, Ido M, Gotou M, Takahito A, Kousaka J, Nakano S.   +9 more
europepmc   +1 more source